2019 annual financial data
Bionano Genomics 2019 Operating cash flow growth
Direct answer
Operating cash flow growth was -48.06%.
Operating income was -25,874,906 USD and net income was -29,836,118 USD.
Operating cash flow was -29,529,720 USD.
Get free Bionano Genomics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,129,508 USD
- Operating income
- -25,874,906 USD
- Net income
- -29,836,118 USD
- Operating cash flow
- -29,529,720 USD